FDx Advisors Inc. Decreases Stake in Johnson Controls International plc (NYSE:JCI)

FDx Advisors Inc. lessened its position in shares of Johnson Controls International plc (NYSE:JCI) by 6.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,318 shares of the company’s stock after selling 318 shares during the quarter. FDx Advisors Inc.’s holdings in Johnson Controls International were worth $335,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Capital World Investors raised its stake in Johnson Controls International by 85.5% during the first quarter. Capital World Investors now owns 14,142,736 shares of the company’s stock valued at $923,804,000 after purchasing an additional 6,520,580 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its position in shares of Johnson Controls International by 686.4% during the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 4,445,418 shares of the company’s stock valued at $295,487,000 after buying an additional 3,880,146 shares in the last quarter. M&G Plc bought a new position in shares of Johnson Controls International in the 1st quarter valued at about $120,948,000. Toronto Dominion Bank increased its stake in Johnson Controls International by 413.5% during the first quarter. Toronto Dominion Bank now owns 1,935,465 shares of the company’s stock worth $126,425,000 after acquiring an additional 1,558,560 shares during the last quarter. Finally, Ceredex Value Advisors LLC purchased a new stake in Johnson Controls International during the second quarter valued at approximately $73,881,000. Institutional investors own 90.05% of the company’s stock.

Johnson Controls International Stock Up 2.3 %

Shares of NYSE JCI opened at $86.60 on Tuesday. Johnson Controls International plc has a 52-week low of $50.60 and a 52-week high of $87.16. The firm has a market capitalization of $57.85 billion, a price-to-earnings ratio of 34.09, a PEG ratio of 2.46 and a beta of 1.29. The stock has a 50 day moving average price of $75.32 and a 200 day moving average price of $71.02. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.73 and a current ratio of 0.94.

Johnson Controls International Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Wednesday, September 25th were issued a $0.37 dividend. The ex-dividend date of this dividend was Wednesday, September 25th. This represents a $1.48 annualized dividend and a dividend yield of 1.71%. Johnson Controls International’s payout ratio is currently 58.27%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on JCI. Mizuho lifted their target price on Johnson Controls International from $62.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Royal Bank of Canada raised their price target on Johnson Controls International from $81.00 to $86.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 7th. Bank of America boosted their price objective on shares of Johnson Controls International from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Barclays raised their target price on shares of Johnson Controls International from $62.00 to $64.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 2nd. Finally, StockNews.com downgraded shares of Johnson Controls International from a “buy” rating to a “hold” rating in a report on Tuesday. Twelve analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Johnson Controls International currently has a consensus rating of “Hold” and an average target price of $75.64.

Insider Buying and Selling

In other Johnson Controls International news, CEO George Oliver sold 110,615 shares of the firm’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $72.67, for a total transaction of $8,038,392.05. Following the transaction, the chief executive officer now owns 1,243,751 shares of the company’s stock, valued at approximately $90,383,385.17. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Johnson Controls International news, CEO George Oliver sold 110,615 shares of the stock in a transaction on Monday, September 16th. The stock was sold at an average price of $72.67, for a total transaction of $8,038,392.05. Following the sale, the chief executive officer now owns 1,243,751 shares of the company’s stock, valued at approximately $90,383,385.17. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Nathan D. Manning sold 3,000 shares of the business’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $77.08, for a total value of $231,240.00. Following the completion of the transaction, the chief operating officer now directly owns 140,488 shares of the company’s stock, valued at approximately $10,828,815.04. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 226,141 shares of company stock valued at $16,904,519 over the last three months. 0.69% of the stock is owned by company insiders.

Johnson Controls International Profile

Johnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the United States, Europe, the Asia Pacific, and internationally. It operates in four segments: Building Solutions North America, Building Solutions EMEA/LA, Building Solutions Asia Pacific, and Global Products.